Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,400
Closed -$218K 4322
2024
Q1
$218K Hold
17,400
﹤0.01% 3007
2023
Q4
$267K Buy
+17,400
New +$243K ﹤0.01% 3050
2021
Q3
Sell
-100
Closed -$3K 5775
2021
Q2
$3K Buy
+100
New +$2.66K ﹤0.01% 4887
2021
Q1
Sell
-11,200
Closed -$209K 5515
2020
Q4
$209K Sell
11,200
-4,000
-26% -$71.9K ﹤0.01% 3734
2020
Q3
$235K Buy
15,200
+7,500
+97% +$116K ﹤0.01% 3399
2020
Q2
$118K Buy
7,700
+3,500
+83% +$52K ﹤0.01% 3725
2020
Q1
$54K Buy
+4,200
New +$75.2K ﹤0.01% 3566

Other funds holding TBI

PEAK6 Investments's TBI Position: Q2 2024 in Review

PEAK6 Investments sold out of Trueblue (TBI) in Q2 2024, closing a stake of 3,202 shares — an estimated $40.1K sold.

PEAK6 Investments first reported a position in TBI in Q4 2020 and held it in 3 quarters. The position peaked at $40.1K in Q1 2024. 121 funds tracked by Wall St. Rank hold TBI as of Q2 2024.

  • PEAK6 Investments reported no remaining Trueblue position as of Q2 2024 after selling out during the quarter.
  • PEAK6 Investments sold 3,202 Trueblue shares in Q2 2024, an estimated $40.1K.
  • PEAK6 Investments first reported a position in Trueblue in Q4 2020 and held it in 3 quarters.
  • PEAK6 Investments's Trueblue position peaked at $40.1K in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Trueblue as of Q2 2024.

Based on PEAK6 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.